Advertisement

Topics

Cellectis??? UCART123 Administered To First Patient With BPDCN In Phase I Clinical Trial At MD Anderson Cancer Center

20:00 EDT 17 Aug 2017 | BioSpace

  Life Sciences Jobs   ...

Original Article: Cellectis??? UCART123 Administered To First Patient With BPDCN In Phase I Clinical Trial At MD Anderson Cancer Center

NEXT ARTICLE

More From BioPortfolio on "Cellectis??? UCART123 Administered To First Patient With BPDCN In Phase I Clinical Trial At MD Anderson Cancer Center"

Advertisement
Quick Search
Advertisement
Advertisement